| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |